RIDDLE&CODE
17.3.2022 10:17:06 CET | Business Wire | Press release
The consortium formed by Dyne.org, RIDDLE&CODE and InfoCert has entered the second phase of the European Blockchain Services Infrastructure (EBSI) project and will receive support to further develop and test its multilayered blockchain stack ZENBRIDGE.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220317005181/en/
Led by the European Commission and 29 member countries that collaborate as a European Blockchain Partnership (EBP), EBSI aims to develop highly secure and compliant cross-border public services on a European level. This involves overcoming gaps in the existing blockchain applications and delivering more demanding solutions that reduce environmental footprint and comply with EU legal frameworks such as the GDPR. The second phase of the project was launched on December 20, 2021, and will run until the end of June 2022.
Some use cases include management and exploitation of data, tracking of digital records and the rights associated with them, automation of tasks through smart contracts and development of incentive models through tokenization of both physical and digital assets.
ZENBRIDGE, a state-of-the-art decentralized system, offers distributed, secure execution of smart contracts and is integrated with blockchain frameworks such as BigchainDB, PlanetMINT, Ethereum, Hyperledger Fabric, Hyperledger Sawtooth and Bitcoin. The system is designed to deliver high-velocity performance, ensure sustainability and provide superior levels of data sovereignty as well as interoperability between various blockchain networks and legacy systems.
During this second phase, research and development results will be lab-tested. Based on these outcomes, a minimum of three projects will be selected for the final Phase (2B), which will run for an additional 12 months and result in real-world field testing.
Quotes from the consortium members:
Thomas Fürstner (Founder & CTO, RIDDLE&CODE): “The expertise of our consortium will hopefully convince the European Commission to make use of blockchain technology as a multipurpose tool to secure both the value of digital assets and data. At the ‘layer zero’, RIDDLE&CODE will work to connect productive machines and sensors with the security of banking-grade backends. This will allow us to establish trusted digital product passports for physical items in motion across Europe and ensure compliance with the European regulatory frameworks in a transparent way.”
Denis “Jaromil” Roio , (Founder and CTO of Dyne.org): “In our success within the EBSI procurement process, we see a big opportunity to provide the European ICT industry with environmentally sustainable solutions that are free and open to community-based adoption models. We leverage cryptography beyond some common financial sector use cases, making it easy to retrofit and recycle legacy infrastructure. Our solution is free from the speculation and waste of crypto-markets, supports computation on low-power embedded hardware and supports future-proof building blocks that are quantum-resistant. With the ZENBRIDGE stack, a developer can go from a smart contract to a ready-to-use wallet app implementation for digital product passports in a week.”
Carmine Auletta (Chief Strategy and Innovation Officer, InfoCert - Tinexta Group): “We’re pleased with the results achieved by the consortium in Phase 1 and proud of the support and trust placed in us to further develop the project in its second phase. Distributed Ledger Technologies will play an important role in the EU digital market and a key component to their market uptake will inevitably be played by their Governance & Trust Framework. Our consortium partners have demonstrated extraordinary technical expertise in distributed ledger technologies, while InfoCert has very distinctive experience in creating Trust Frameworks. Joining forces has proved crucial to ZENBRIDGE’s success.”
About RIDDLE&CODE
RIDDLE&CODE is Europe’s leading company for blockchain interface solutions. The company develops hardware and software stacks that combine the security of smart cards with blockchain and the Internet of Things (IoT). Together with its tier-one clients and partners, which include Daimler Mobility, BMW, Wien Energie and leading Dutch crypto exchange LiteBit, RIDDLE&CODE brings new business models to the fintech, energy, mobility and materials industries.
More information: www.riddleandcode.com
About Dyne.org
Dyne.org is a non-profit foundation dedicated to free and open-source software and community development with 20 years of expertise in developing applications used worldwide. With the motto “we are free to share code and we code to share freedom”, its projects include independent streaming software for free speech, privacy tools for activists and GNU/Linux distributions.
More information: dyne.org
About InfoCert
InfoCert, Tinexta Group, is the largest European certification authority, active in over twenty countries. The company provides services in digitisation, eDelivery, Digital Signature and digital preservation of documents and is an accredited AgID digital identity operator in the area of SPID (Public System for the management of Digital Identity). The company holds a 60% stake in CertEurope, the biggest certification authority in France; a 51% stake in Camerfirma, one of the principal Spanish certification authorities; a 16.7% stake in Authada, a leading-edge German Identity Provider; and 80% of Sixtema S.p.A.
More information: infocert.digital
View source version on businesswire.com: https://www.businesswire.com/news/home/20220317005181/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom